{Reference Type}: Journal Article
{Title}: Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach.
{Author}: Swain SK;Panda S;Sahu BP;Mahapatra SR;Dey J;Sarangi R;Misra N;
{Journal}: Clin Exp Vaccine Res
{Volume}: 13
{Issue}: 2
{Year}: 2024 Apr
暂无{DOI}: 10.7774/cevr.2024.13.2.132
{Abstract}: <B>UNASSIGNED: </B>Enterovirus 71, a pathogen that causes hand-foot and mouth disease (HFMD) is currently regarded as an increasing neurotropic virus in Asia and can cause severe complications in pediatric patients with blister-like sores or rashes on the hand, feet, and mouth. Notwithstanding the significant burden of the disease, no authorized vaccine is available. Previously identified attenuated and inactivated vaccines are worthless over time owing to changes in the viral genome.<BR><B>UNASSIGNED: </B>A novel vaccine construct using B-cell derived T-cell epitopes from the virulent polyprotein found the induction of possible immune response. In order to boost the immune system, a beta-defensin 1 preproprotein adjuvant with EAAAK linker was added at the N-terminal end of the vaccine sequence.<BR><B>UNASSIGNED: </B>The immunogenicity of the designed, refined, and verified prospective three-dimensional-structure of the multi-epitope vaccine was found to be quite high, exhibiting non-allergenic and antigenic properties. The vaccine candidates bound to toll-like receptor 3 in a molecular docking analysis, and the efficacy of the potential vaccine to generate a strong immune response was assessed through in silico immunological simulation.<BR><B>UNASSIGNED: </B>Computational analysis has shown that the proposed multi-epitope vaccine is possibly safe for use in humans and can elicit an immune response.